Ecuador vs Philippines: Average cost of drugs for extensively drug-resistant tuberculosis

Ecuador

451 constant 2022 US$

in 2024

Philippines

282 constant 2022 US$

in 2024

Ecuador rank

50th

Philippines rank

52nd

Average cost of drugs for extensively drug-resistant tuberculosis over time

Ecuador currently reports 451 constant 2022 US$ against 282 constant 2022 US$ in Philippines, a difference of 169 constant 2022 US$.

That makes Ecuador's figure about 1.6 times Philippines's.

The two have swapped places 2 times across 5 shared years of data; in 2017 it was Ecuador ahead.

Ecuador ranks 50th and Philippines ranks 52nd of 56 countries.

Indicator: Average cost of drugs for extensively drug-resistant tuberculosis
Unit: constant 2022 US$
Source: WHO (2025) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 56 places, 394 data points, 2017–2024
Last refreshed: 07 August 2026

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.